Stock 300238 GUANHAO BIOTECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guanhao Biotech Co.,Ltd.

Equities

300238

CNE100001575

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
9.91 CNY +4.10% Intraday chart for Guanhao Biotech Co.,Ltd. +10.97% -26.92%
Apr. 25 Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 05 Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,530 5,067 6,666 4,913 2,726 3,596
Enterprise Value (EV) 1 2,722 5,196 6,717 4,905 2,679 3,545
P/E ratio 56.1 x -10.9 x 140 x 66.2 x -8.86 x 113 x
Yield - - - - - -
Capitalization / Revenue 5.52 x 11.6 x 15.3 x 10 x 7.22 x 8.9 x
EV / Revenue 5.94 x 11.9 x 15.4 x 10 x 7.1 x 8.77 x
EV / EBITDA 45.6 x -116 x 101 x 52.5 x -79.7 x 58.3 x
EV / FCF -34.5 x 178 x 81.1 x 57.5 x 51.9 x 143 x
FCF Yield -2.9% 0.56% 1.23% 1.74% 1.93% 0.7%
Price to Book 2.19 x 7.12 x 9.13 x 6.27 x 5.62 x 6.91 x
Nbr of stocks (in thousands) 265,156 265,156 265,156 265,156 265,156 265,156
Reference price 2 9.540 19.11 25.14 18.53 10.28 13.56
Announcement Date 4/25/19 4/24/20 3/8/21 4/14/22 4/20/23 3/5/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 458.5 437.9 437 489 377.3 404.2
EBITDA 1 59.7 -44.62 66.61 93.35 -33.61 60.81
EBIT 1 34.11 -75.39 38.84 67.49 -56.29 39.65
Operating Margin 7.44% -17.22% 8.89% 13.8% -14.92% 9.81%
Earnings before Tax (EBT) 1 52.07 -484.9 44.88 82.06 -292.6 32.09
Net income 1 45.75 -465.3 46.59 73.69 -307.8 31.01
Net margin 9.98% -106.27% 10.66% 15.07% -81.59% 7.67%
EPS 2 0.1700 -1.750 0.1800 0.2800 -1.160 0.1200
Free Cash Flow 1 -78.99 29.21 82.79 85.28 51.64 24.86
FCF margin -17.23% 6.67% 18.95% 17.44% 13.69% 6.15%
FCF Conversion (EBITDA) - - 124.29% 91.35% - 40.88%
FCF Conversion (Net income) - - 177.68% 115.73% - 80.17%
Dividend per Share - - - - - -
Announcement Date 4/25/19 4/24/20 3/8/21 4/14/22 4/20/23 3/5/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 193 128 51.4 - - -
Net Cash position 1 - - - 7.93 47.2 50.5
Leverage (Debt/EBITDA) 3.23 x -2.879 x 0.7723 x - - -
Free Cash Flow 1 -79 29.2 82.8 85.3 51.6 24.9
ROE (net income / shareholders' equity) 2.97% -52.8% 5.82% 6.93% -55.6% 4.75%
ROA (Net income/ Total Assets) 1.25% -3.38% 2.13% 3.78% -3.98% 3.67%
Assets 1 3,667 13,768 2,192 1,951 7,739 843.9
Book Value Per Share 2 4.350 2.680 2.750 2.960 1.830 1.960
Cash Flow per Share 2 0.3900 0.5300 0.5900 0.6000 0.4800 0.4000
Capex 1 33.6 6.32 2.9 4.71 41.2 53.9
Capex / Sales 7.34% 1.44% 0.66% 0.96% 10.91% 13.34%
Announcement Date 4/25/19 4/24/20 3/8/21 4/14/22 4/20/23 3/5/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
GUANHAO BIOTECH CO.,LTD. Stock Guanhao Biotech Co.,Ltd.
-26.92% 363M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 186B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 67.44B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 50.03B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 47.81B
HOYA CORPORATION Stock Hoya Corporation
+4.79% 41.03B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.85B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 25.82B
TERUMO CORPORATION Stock Terumo Corporation
+16.55% 24.74B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 300238 Stock
  4. Financials Guanhao Biotech Co.,Ltd.